Cost Of Revenue - EC Healthcare (HKEX:2138) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 1.4 HKD

Updated:

EC Healthcare
Cost of Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

EC Healthcare
Cost of Revenue Peer Comparison

1830

W

1161

1827

I

8029

A

922

Company		Cost of Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	EC Healthcare HKEX:2138	Cost of Revenue -HK$553m	CAGR 3-Years -37%	CAGR 5-Years -28%	CAGR 10-Years N/A
	Perfect Medical Health Management Ltd HKEX:1830	Cost of Revenue -HK$32.5m	CAGR 3-Years -29%	CAGR 5-Years -18%	CAGR 10-Years N/A
W	Water Oasis Group Ltd HKEX:1161	Cost of Revenue -HK$95.7m	CAGR 3-Years -24%	CAGR 5-Years -12%	CAGR 10-Years -3%
	Miricor Enterprises Holdings Ltd HKEX:1827	Cost of Revenue -HK$47.4m	CAGR 3-Years -39%	CAGR 5-Years -30%	CAGR 10-Years N/A
I	Imperium Financial Group Ltd HKEX:8029	Cost of Revenue -HK$17m	CAGR 3-Years -183%	CAGR 5-Years 20%	CAGR 10-Years 14%
A	Anxian Yuan China Holdings Ltd HKEX:922	Cost of Revenue -HK$81.4m	CAGR 3-Years 15%	CAGR 5-Years -7%	CAGR 10-Years -3%

See Also

Based on the financial report for Mar 31, 2023, EC Healthcare's Cost of Revenue amounts to -553m HKD.

Over the last year, the Cost of Revenue growth was -58%. The average annual Cost of Revenue growth rates for EC Healthcare have been -37% over the past three years , -28% over the past five years .

Join more than 133,900+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.